Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Quantum BioPharma Ltd C.QNTM

Alternate Symbol(s):  QNTM

Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The Company is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. It maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.


CSE:QNTM - Post by User

Post by BigDogMacon May 12, 2023 8:46am
175 Views
Post# 35445006

Substance Abuse History

Substance Abuse HistoryOh DavidRosenberg, - thank you for the history lesson but as usual you like to spin things. Maybe stick with your day job as a DJ.

It appears Raza was very aware of Saeed's substance and alcohol abuse and brought it to the attention of the entire Board

December 20, 2020.

This letter bears reproducing here: Dear Mr. Saeed: Re: Administrative Leave and Investigation I am writing to you in my capacity as Executive Chairman and Chief Executive Officer of FSD Pharma Inc. (“FSD” or the “Company”). This letter confirms a decision taken by me in consultation with, and with the consent of, a majority of the members of the Board of Directors of FSD (the “Board”) to place you on administrative leave, effective immediately, pending completion of an investigation into escalating concerns that you have engaged in serious misconduct inconsistent with your responsibilities as President and a director of FSD. The concerns identified thus far include, but are not limited to, your disclosure of highly sensitive and confidential information about the Company and its partners to third parties in breach of your fiduciary duties, your employment agreement effective May 29, 2019 (the “Employment Agreement”), and FSD’s contractual confidentiality obligations owed to third parties, as well as a failure to comply with the FSD’s Corporate Disclosure Policy. In addition, you have willfully neglected your duties and failed to perform the essential responsibilities of your roles with FSD, including by, but not limited to, the use of illicit substances, and related intoxication in the workplace, and board and shareholder meetings. Your apparent actions and inactions have caused serious reputational and operational harm to the Company and, if proven, constitute just cause for dismissal.

Yours truly, Raza Bokhari, MD Executive Chairman & CEO
<< Previous
Bullboard Posts
Next >>